Study Identifies B Cells as Drivers of Immunotherapy-Related Colitis
A recent study has identified B cells as key drivers of colitis associated with immunotherapy treatments. This discovery sheds light on the immune mechanisms behind this side effect, potentially guiding better management and therapeutic strategies for patients undergoing immunotherapy.
Google News·1d ago

